Hydrus Microstent vs Goniotomy for Glaucoma
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to evaluate the comparative efficacy and safety of Hydrus Microstent, incisional goniotomy, and excisional goniotomy when combined with cataract surgery in patients with mild and moderate open-angle glaucoma. The main questions it aims to answer are: * How do the intraocular pressure lowering effects of these three microinvasive glaucoma surgeries compare? * How do the safety profiles of these three microinvasive glaucoma surgeries compare? Participants will be randomized to one of these three microinvasive glaucoma surgeries in combination with cataract surgery.
Eligibility Criteria
This trial is for patients with mild to moderate open-angle glaucoma who also need cataract surgery. They should have a certain level of visual field mean deviation and intraocular pressure (IOP) between 10 to 31 mm Hg. Participants must understand the study and commit to follow-up exams.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo one of three microinvasive glaucoma surgeries (Hydrus Microstent, incisional goniotomy, or excisional goniotomy) in combination with cataract surgery
Follow-up
Participants are monitored for safety and effectiveness after surgery
Treatment Details
Interventions
- Excisional goniotomy (Procedure)
- Hydrus Microstent (Device)
- Incisional goniotomy (Procedure)